Company linked to meningitis cases paid execs more than $20M last year

, The National Law Journal

   | 1 Comments

The Massachusetts pharmaceutical company linked to a fungal meningitis outbreak that caused 44 deaths has reported nearly $21.2 million in both salaries to key executives and credit card reimbursements since December 2011.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • Legal Assistant

    It's hard to say if the two events are connected by anything but poor management. However, I wouldn't be surprised if the lack of fiscal conservatism led to cutting corners in manufacturing to reduce costs. Someone's got to pay for the executives' groceries at Whole Foods...oh wait, they get a salary too don't they?

    Phoenix Personal Injury Lawyer

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202585347098

Thank you!

This article's comments will be reviewed.